Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Walgreens Boots Alliance    WBA

WALGREENS BOOTS ALLIANCE

(WBA)
  Report  
Delayed Quote. Delayed Nasdaq - 11/12 04:00:00 pm
62.72 USD   +0.76%
11/12Wall Street in full speed
11/12WALGREENS BOOTS ALLIANCE : shares rise amid 'KKR buyout interest'
AQ
11/11Tupperware, Qualcomm fall; Walgreens, SunPower rise
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Walgreens Boots Alliance : The U.S. opioid epidemic by the numbers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/21/2019 | 06:26pm EST

(Reuters) - Opioid deaths in the United States have soared over the last two decades, driving a wave of litigation against drugmakers and distributors.

The following is a look at the scale of the epidemic and the related legal battles. Numbers relating to opioid use, illnesses and deaths are based on information from the U.S. Centers for Disease Control and Prevention.

** Deaths linked to overdoses of opioids in U.S., including illegal drugs like heroin, from 1990 to 2017: nearly 400,000

** Number of those deaths linked to prescription opioids: about 218,000

** Average number of opioid overdose deaths in the United States per day: about 130

** Percentage of drug overdose deaths that involved an opioid in 2017: 67.8%

** Number of opioid prescriptions dispensed in the U.S. in 2017: 191,218,272

** Share of U.S. population that had at least one opioid prescription filled in 2017: 17.4 percent

** Lawsuits pending nationwide over opioids: approximately 2,600

** Lawsuits consolidated before U.S. District Judge Dan Polster in Cleveland, Ohio: approximately 2,300

** Value of largest single settlement in an opioid lawsuit: $270 million, between now-bankrupt OxyContin maker Purdue Pharma LP and its controlling Sackler family and the state of Oklahoma. Purdue and the Sacklers have denied wrongdoing.

** Number of opioid makers that have filed for bankruptcy: two

(Reporting By Brendan Pierson in New York; Editing by Noeleen Walder and Steve Orlofsky)

By Brendan Pierson

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE
11/12Wall Street in full speed
11/12WALGREENS BOOTS ALLIANCE : shares rise amid 'KKR buyout interest'
AQ
11/11Tupperware, Qualcomm fall; Walgreens, SunPower rise
AQ
11/11WALL STREET STOCK EXCHANGE : S&P 500, Nasdaq slip on trade uncertainty
RE
11/11WALL STREET STOCK EXCHANGE : S&P 500, Nasdaq slip on trade uncertainty; Boeing b..
RE
11/11MARKETS RIGHT NOW : Stocks fall on uncertainty over trade
AQ
11/11Walgreens Up Over 6% After Reported Buyout Offer -- Data Talk
DJ
11/08Health Care Up After Strong Week For Earnings -- Health Care Roundup
DJ
11/07Health Care Up After Teva, Cardinal Health Reports -- Health Care Roundup
DJ
11/07Cardinal Health Posts 1Q Loss, Driven by Litigation Charges
DJ
More news
Financials (USD)
Sales 2020 140 B
EBIT 2020 6 767 M
Net income 2020 4 348 M
Debt 2020 14 004 M
Yield 2020 3,09%
P/E ratio 2020 12,0x
P/E ratio 2021 11,5x
EV / Sales2020 0,48x
EV / Sales2021 0,46x
Capitalization 53 097 M
Chart WALGREENS BOOTS ALLIANCE
Duration : Period :
Walgreens Boots Alliance Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 25
Average target price 57,32  $
Last Close Price 59,49  $
Spread / Highest target 9,26%
Spread / Average Target -3,65%
Spread / Lowest Target -24,4%
EPS Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
Richard M. Ashworth President-Operations
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIANCE-8.21%53 097
MCKESSON CORPORATION27.04%24 442
CARDINAL HEALTH20.36%15 038
SINOPHARM GROUP CO. LTD.-16.26%10 564
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD8.24%6 863
WELCIA HOLDINGS CO., LTD.29.47%6 126